tolerx.com

Tolerx, Inc.

Tolerx, Inc.'s email is info@tolerx.com and Tolerx, Inc.'s phone number is (617)452-1300 .

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.
View Top Employees for Tolerx, Inc.
img Website tolerx.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 9
img Founded 2000
img HQ 300 Technology Square 3rd Floor
img Phone (617)452-1300
img Email info@tolerx.com
img Funding 145,500,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website tolerx.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 9
img Founded 2000
img LinkedIn linkedin.com/company/tolerx-inc.
img HQ 300 Technology Square 3rd Floor
img Phone (617)452-1300
img Email info@tolerx.com
img Funding 145,500,000 USD

Top Tolerx, Inc. Employees